GW Pharmaceuticals Share Price (GWP)
| Bid price | 78.00 | Open price | 80.00 |
|---|---|---|---|
| Ask price | 80.00 | Prev close | 79.00 |
| High price | 80.00 | Spread | 2.50% |
| Low price | 78.00 | Volume | 26,884 |
Register now for FREE live GW Pharmaceuticals share prices, GW Pharmaceuticals stock quotes, charts, trades and FREE GW Pharmaceuticals company fundamentals, market news and much much more. Why not upgrade to a premium service and get GW Pharmaceuticals Level 2 Data, indepth research tools and investor commentary for GW Pharmaceuticals (GWP) and other London Stock Exchange equities.
GW Pharmaceuticals Share Price Chart
Register now for FREE GW Pharmaceuticals share price charts
GW Pharmaceuticals Share Price Information
| Name | GW Pharmaceuticals | Epic | GWP |
|---|---|---|---|
| Activites | Develops a range of new medicines based on cannabis and other controlled drugs | Reuters | GWP.L |
| ISIN | GB0030544687 | Google Finance | LON:GWP |
| Share Price (p) | 79.00 | Prev. Share Price (p) | 79.00 |
|---|---|---|---|
| Shares in Issue (m) | 133 | Market Cap (£m) | 104 |
| PE Ratio (x) | 46.67 | Div per share (p) | 0.00 |
| Div yield (%) | 0.00 | Div cover (x) | |
| EPS (p) | 2.10 | PEG | 1.60 |
Register now for FREE GW Pharmaceuticals company fundamentals
GW Pharmaceuticals Director Deals
| Dec.Date | Type | Director | Pos | No. of Shares |
|---|---|---|---|---|
| 02/04/2012 | EXR | Stephen Wright | ED | 140,000 |
| 02/04/2012 | SEXR | Stephen Wright | ED | 140,000 |
| 30/03/2012 | TOUT | Geoffrey Guy | CH | 365,000 |
| 28/12/2011 | BUY | Richard Forrest | NED | 10,000 |
| 12/10/2011 | BUY | Richard Forrest | NED | 10,000 |
GW Pharmaceuticals Company News
Director/PDMR Shareholding
/* */ RNS Number : 9724D GW Pharmaceuticals PLC 23 May 2012 GW Pharmaceuticals PLC Director/PDMR Shareholding GW Pharmaceuticals PLC 23 May 2012 GW Pharmaceuticals PLC GW Pharmaceuticals PLC ("GW Pharmaceuticals" or the "Company") NOTIFICATION...
GW Pharmaceuticals net loss in line with forecasts
GW Pharmaceuticals posts a net loss of £4.1m for the six months to the end of March against a profit of £3.1m last time. The company says the loss is in line with expectations, and reflects the fact that no major new Sativex country launches had been anticipated in the period nor had the group...
FLASH: GW Pharmaceuticals' Sativex in phase III trial
Story provided by StockMarketWire.com
More GW Pharmaceuticals Company News >>
Register now for FREE GW Pharmaceuticals company news
GW Pharmaceuticals Share Price Discussions
GW.Parmaceuticals the cannabis drug co. going high has a kite! (GWP)
NO COMPETITION AND NO SIDE AFFECTS...PUT YA TRUST IN THIS GREAT COMPANY !
GWP to fly on this massive news? $33m licence agreement (GWP)
RNS Number : 6161E GW Pharmaceuticals PLC 11 April 2011 GW Signs Exclusive Licence Agreement to Commercialise Sativex® in Australia, Asia, Middle-East and Africa Porton Down, UK; 11 April 2011: GW Pharmaceuticals plc (AIM:GWP) today announces that it has entered into an...
MRHA VIRTUALLY APPROVE SATIVEX DUE TO PUBLIC DEMAND (GWP)
Report GW Pharmaceuticals Re Sativex RNS Number:8627J GW Pharmaceuticals PLC 13 December 2007 GW Welcomes Move by UK Regulator to Provide More Information for Sativex(R) Prescribers Porton Down, UK; 13 December 2007: GW Pharmaceuticals plc (AIM: GWP) welcomes the...
Register now for FREE GW Pharmaceuticals share price discussions